An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

意大利研究人员针对儿童肥胖症这一全球健康挑战，系统评估了当前药物疗法的临床价值与局限性。研究表明，胰高血糖素样肽-1(GLP-1)受体激动剂semaglutide和liraglutide在青少年群体中展现出显著减重效果，但存在胃肠道不良反应、停药反弹风险及治疗成本等问题。

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

The glucagon-like peptide-1 (GLP-1) analogues liraglutide and semaglutide are approved by the Food and Drug Administration and the European Medicines Agency for long-term weight management in ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study.

Study: One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice.Image Credit: Pixel-Shot / Shutterstock.com. A recent JAMA Network Open study compares the weight loss ...

New research reveals that liraglutide, a GLP-1 receptor agonist, crosses the blood-brain barrier to target specific neurons, reducing appetite and promoting lasting weight loss. Liraglutide, a ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...

Liraglutide and Semaglutide Market Research Report 2024: Market to Reach $51.83 Billion by 2034 from $15.87 Billion in 2023 - ResearchAndMarkets.com March 11, 2025 03:19 PM Eastern Daylight Time ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Liraglutide is especially appealing for these companies, since it’s the closest thing they can safely produce and sell that still qualifies as a kind of Ozempic dupe. Some are even marketing it ...